Zobrazeno 1 - 10
of 4 373
pro vyhledávání: '"cancer‐specific survival"'
Autor:
Liu L
Publikováno v:
Risk Management and Healthcare Policy, Vol Volume 17, Pp 2959-2970 (2024)
Linli Liu Department of Gynecology, Fuzhou First General Hospital, Affiliated to Fujian Medical University, Taijiang District, Fuzhou, Fujian, People’s Republic of ChinaCorrespondence: Linli Liu, Department of Gynecology, Fuzhou First General Hospi
Externí odkaz:
https://doaj.org/article/2bd53d9085634202b141ecd0d50e672b
Autor:
Hong Guo, Doctor of Medicine (M.D.), Guole Nie, Doctor of Medicine (M.D.), Xin Zhao, Master of Medicine (M.M.), Jialu Liu, Master of Medicine (M.M.), Kaihua Yu, Master of Medicine (M.M.), Yulan Li, Doctor of Medicine (M.D.)
Publikováno v:
Surgery Open Science, Vol 22, Iss , Pp 13-23 (2024)
Background: Non-small cell lung cancer (NSCLC) accounts for 85 % of lung cancer cases. Among NSCLC subtypes, lung adenocarcinoma (LUAD) stands as the most prevalent. Regrettably, LUAD continues to exhibit a notably unfavorable overall prognosis. This
Externí odkaz:
https://doaj.org/article/39b2944778d943ccb4ac128dc1d72101
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-18 (2024)
Abstract Purpose The aim of the study is to identify risk factors for the prognosis and survival of synchronous colorectal cancer and to create and validate a functional Nomogram for predicting cancer-specific survival in patients with synchronous co
Externí odkaz:
https://doaj.org/article/468cea4e64934c6a96f48838481e870f
Publikováno v:
BMC Women's Health, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Metaplastic breast carcinoma (MpBC) is a rare histological subtype of breast cancer, and its prognosis is relatively poor. The survival trend of MpBC with different hormone receptor statuses has remained unclear over the past two
Externí odkaz:
https://doaj.org/article/fec5f19daa2140598ad97ed9c90d4465
Autor:
Zhengshui Xu, Zhenchuan Ma, Feng Zhao, Jianzhong Li, Ranran Kong, Shaomin Li, Jiantao Jiang, Huafeng Kang, Dandan Liu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Recently, several studies have reported that the survival benefit of wedge resection might not be inferior to that of lobectomy in early-stage NSCLC patients, but there is no unified definition of the details or cutoff value. Patients with e
Externí odkaz:
https://doaj.org/article/4352c2b1f0f34c49bad16041ad78437f
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Background To investigate the prognostic differences following the achievement of a pathological complete response (pCR) through neoadjuvant chemotherapy across different molecular subtypes of breast invasive ductal carcinoma. Methods Data f
Externí odkaz:
https://doaj.org/article/a28c1a4eeb944f44841e1190ea5c1ab5
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract The prognosis of poorly differentiated lung adenocarcinoma (PDLA) is determined by many clinicopathological factors. The aim of this study is identifying prognostic factors and developing reliable nomogram to predict the overall survival (OS
Externí odkaz:
https://doaj.org/article/0d0cb678a8164e6bb1ed2ec5a2d66341
Autor:
Fiorella L. Roldan, Ugo Giovanni Falagario, Mats Olsson, Rodolfo Sánchez Salas, Markus Aly, Lars Egevad, Anna Lantz, Henrik Grönberg, Olof Akre, Abolfazl Hosseini, N. Peter Wiklund
Publikováno v:
BJUI Compass, Vol 5, Iss 9, Pp 885-892 (2024)
Abstract Objective The aim of this study is to evaluate treatment patterns and long‐term oncological outcomes of patients with locally advanced prostate cancer (LAPCa). Patients and methods This is a population‐based study including LAPC (cT3‐4
Externí odkaz:
https://doaj.org/article/4b381aec03d14e97aa1cbafc5fe70133
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract The role of neoadjuvant chemotherapy and its benefits in patients with triple-negative breast cancer (TNBC) and small tumors are unclear. This study aims to compare survival differences between clinical T1 TNBC receiving neoadjuvant chemothe
Externí odkaz:
https://doaj.org/article/f3a0093d04554d6b9e4a42f77aa917ef
Autor:
Alessandro Brunelli, MD, Joshil Lodhia, MD, Richard Milton, MD, Marco Nardini, MD, Kostas Papagiannopoulos, MD, Peter Tcherveniakov, MD, Demetrios Stefanou, MD, Elaine Teh, MD, Nilanjan Chaudhuri, MD
Publikováno v:
JTCVS Open, Vol 20, Iss , Pp 167-173 (2024)
Objective: To evaluate the oncologic outcome of patients with hypermetabolic tumors resected by segmentectomy or lobectomy. Methods: This was a retrospective analysis of all consecutive patients with peripheral clinical stage IA1-2 non–small cell l
Externí odkaz:
https://doaj.org/article/034060ac1a03432e91c0f625c7568a57